title: Can low molecular weight heparins circumvent the problem of coumadine and chemotherapy interaction in cancer patients with prosthetic heart valves?
authors.affiliation: Department of Medical Oncology, Baskent University School of Medicine, Turkey E-mail : drtanersu@ yahoo.com.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Sezer
authors.forename: Ahmet Taner
authors.initials: AT
authors.lastname: Sumbul
authors.forename: Gulcan
authors.initials: G
authors.lastname: Abali
authors.forename: Zehra
authors.initials: Z
authors.lastname: Sumbul
authors.forename: Sadik
authors.initials: S
authors.lastname: Muallaoglu
authors.forename: Huseyin
authors.initials: H
authors.lastname: Abali
mesh_terms: D000368:Aged; D005260:Female; D006350:Heart Valve Prosthesis; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin